Drug-device Combination Products Market Overview, High Growth Opportunities, Segmentation, Trends By 2021-2028

Rise in Prevalence of Chronic Diseases to Dominate Global Market

The increase in prevalence of chronic diseases and disorders such as cancer, cardiac conditions, multiple sclerosis, and diabetes is expected to fuel the growth of the global market over the next few years. According to the National Center for Biotechnology Information (NCBI), ischemic heart disease affected around 126 million people (1,655 per 100,000) in 2017, accounting for 1.72% of the global population.

Access Full Report @ https://www.transparencymarketresearch.com/drug-device-combination.html

Transdermal Patches to be Highly Lucrative Segment

In terms of product, the global drug device combination products market has been classified into drug eluting stents, infusion pumps, photosensitizers, orthopedic combination products, wound care combination products, inhalers, transdermal patches, and others. Transdermal patches are the most popular products. This is due to increase in demand for self-administered drugs for diseases that require long-term treatment. Insulin, for instance, must be administered intravenously to diabetic patients on a regular basis. Repeated use of injections to deliver insulin causes pain and increases the risk of infection transmission. Hence, alternative drug delivery modes are expected to gain popularity.

Get a sample of the report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1534

North America to Dominate Global Market

In terms of region, the global drug device combination products market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is projected to be a highly lucrative market for drug-device combination products during the forecast period. Increase in presence of patented nanomedical products across the region is a major factor driving the market. North America dominated the global drug-device combination products market in terms of revenue in 2020, and the trend is expected to continue during the forecast period.

Asia Pacific is likely to be the most lucrative market for drug-device combination products during the forecast period due to increase in incidence of cardiovascular diseases, diabetes-related disorders, and obesity.

Request For Custom Research @ https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=1534

Competition Landscape

The global drug device combination products market is fragmented in terms of number of players. Key players in the global market include Teva Pharmaceutical Industries Ltd., AbbVie, Inc., Abbott Laboratories, Medtronic plc, Kaleo, SINOMED, Alcon, Inc., Boston Scientific Corporation, Integer Holdings Corporation, Teleflex Incorporated, Bausch Health Companies, Inc., Haselmeier GmbH, and Flowonix Medical, Inc.

Global Drug-device Combination Products Market: Segmentation

Make an Enquiry before Buying @ https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=1534

Drug-device Combination Products Market, by Product Type

Drug Eluting Stents

Coronary Stents

Peripheral Vascular Stents

Infusion Pumps

Implantable Infusion Pumps

Ambulatory Infusion Pumps

Photosensitizers

Orthopedic Combination Products

Bone Graft Implants

Antibiotic Loaded Bone Cement

Wound Care Combination Products

Inhalers

Metered Dose Inhalers

Dry Powder Inhalers

Nebulizers

Transdermal Patches

Others

Intraocular Implants

Drug Eluting Beads

More Related Reports by Transparency Market Research -

Glioma Treatment Market : https://www.transparencymarketresearch.com/glioma-treatment-market.html

Diagnostic Reagents Market : https://www.transparencymarketresearch.com/diagnostic-reagents-market.html

Life Care Solution Services Market : https://www.transparencymarketresearch.com/life-care-solution-services-market.html

Transplant Drug Monitoring Assay Market : https://www.transparencymarketresearch.com/transplant-drug-monitoring-assay-market.html

Sensor Based Smart Catheters Market : https://www.transparencymarketresearch.com/sensor-based-smart-catheters-market.html

Hemostasis Diagnostic Analyzers and Reagents Market: https://www.transparencymarketresearch.com/hemostasis-diagnostic-analyzers-reagents-market.html

Fragile X Syndrome Market: https://www.transparencymarketresearch.com/fragile-x-syndrome-market.html

Transthyretin Amyloidosis Treatment Market: https://www.transparencymarketresearch.com/transthyretin-amyloidosis-treatment-market.html

Contact

Rohit Bhisey
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Blog: https://tmrblog.com
Email: sales@transparencymarketresearch.com

About Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services The firm scrutinizes factors shaping the dynamics of demand in various markets. The insights and perspectives on the markets evaluate opportunities in various segments. The opportunities in the segments based on source, application, demographics, sales channel, and end-use are analysed, which will determine growth in the markets over the next decade.

Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers, made possible by experienced teams of Analysts, Researchers, and Consultants. The proprietary data sources and various tools & techniques we use always reflect the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in all of its business reports.

For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update - https://www.youtube.com/channel/UC8e-z-g23-TdDMuODiL8BKQ

This release was published on openPR.